The Teófilo Hernando Foundation and the Spanish National Research Council join forces with... 27/05/2024 Healthcare Access to innovation Drug discovery With this agreement, the FTH takes a fine step forward in its commitment to improve people's health and quality of life. Partners - Fundación Teófilo Hernando (FTH)
Mikrobiomik launches strategic investment round to advance its first medicine based on the... 30/04/2024 Healthcare Drug discovery Rare diseases Innovative drugs The Biscayan biopharmaceutical company, which plans to launch its first biological medicine into the market in the first... Partners - Mikrobiomik
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Healthcare Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
The synergy between biotechnology and immunology catalyzes the development of more effecti... 29/04/2024 Biotechnology has achieved significant advances in diagnosis and precision therapies, the production of biotechnological... AseBio
ORYZON secures another important patent for its lead CNS asset, vafidemstat 22/04/2024 Healthcare Drug discovery Innovative drugs Advanced therapies Has received “Intention to Grant” from the European Patent Office. Partners - Oryzon Genomics
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Antibiotic resistance Biotechnology has radically transformed the discovery of new drugs: 68% of the drugs currently in development globally... AseBio
The "yes" from the European Parliament to the reform of pharmaceutical legislation jeopard... 12/04/2024 We consider that improvements have been made regarding the original proposal, but these continue to be insufficient for... AseBio
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Parkinson's is an extremely debilitating disease, there is no cure, and we only have medications aimed at alleviating... AseBio
Biotechnology seeks solutions for Parkinson's, the second most common neurodegenerative di... 11/04/2024 Approximately 10,000 new cases of Parkinson's are detected each year in Spain, with a total figure exceeding 150,000... AseBio
World Orphan Drug Congress Europe Barcelona Spain Del 22/10/2024 to 25/10/2024 Healthcare Drug discovery International Strategy, Advocacy & Partnering for The Global Orphan Drug Industry.
